• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Jonathan Avery on the Dangers of Misdiagnosing or Mistreating Concurrent Psychiatric and Substance Use Disorders

Video

Jonathan Avery, MD, director of addiction psychiatry, New York-Presbyterian Hospital, Weill Cornell Medical Center, explained why it’s important to diagnose and treat concurrent substance use disorders and mental illnesses at the same time.

Jonathan Avery, MD, director of addiction psychiatry, New York-Presbyterian Hospital, Weill Cornell Medical Center, explained why it’s important to diagnose and treat concurrent substance use disorders and mental illnesses at the same time.

Transcript

What can happen if a psychological disorder is treated but substance use is left undiagnosed or vice versa?

The big problem, I think, in American psychiatry or in medicine in general is that we tend to only treat 1 condition at a time, and often it’s the psychiatric condition and not the substance use disorder condition that gets treated. We think in an ideal world both should be treated at the same time, and if not, if you just treat the psychiatric condition and not the substance use, things aren’t going to get better, and similarly if you address the substance use without addressing the reason why they’re using, it sets the person up for failure. So you really have to address both at the same time if you want the person to get on the right track.

What are the dangers of misdiagnosing a psychiatric disorder when a substance use disorder is present?

Diagnosis can be very challenging when people are using substances. It’s unclear, as we were discussing, if the substance use leads to the mental illness, if the mental illness symptoms wouldn’t be there if they weren’t using a substance. These days, though, we sort of argue that things should be just kept simple, that if it looks like they have depressive symptoms, we don’t have to completely figure out if the substance use was related but they should all be addressed. So if it’s, say, someone who’s depressed and drinking a lot, it might be hard to tease out what started first—if the depression started first or the drinking started first—and our goal would be to recommend that you treat both. You give them medications for the substance, for the alcohol use, or the psychosocial treatment, and you give them meds and therapy if needed for the depression.

Related Videos
Debra Boyer, MD, MHPE, ATSF.
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
ISPOR 2024 Recap
Screenshot of Stephen Freedland, MD, during a video interview
Phaedra Corso, PhD, associate vice president for research at Indiana University
William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Screenshot of Angela Jia, MD, PhD, during a video interview
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Screenshot of Alexander Kutikov, MD, during a video interview
Neil Goldfarb, CEO, Greater Philadelphia Business Coalition on Health
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.